D. Catanzaro

发表

Tuberculosis Treatment Monitoring by Video Directly Observed Therapy in 5 Health Districts, California, USA

F. Raab, R. Garfein, N. Martin, 2018, Emerging infectious diseases.

The Global Consortium for Drug-resistant Tuberculosis Diagnostics (GCDD): design of a multi-site, head-to-head study of three rapid tests to detect extensively drug-resistant tuberculosis

R. Garfein, T. Ganiats, F. Valafar, 2014, Trials.

A Multinational Analysis of Mutations and Heterogeneity in PZase, RpsA, and PanD Associated with Pyrazinamide Resistance in M/XDR Mycobacterium tuberculosis

F. Valafar, A. Catanzaro, L. Fink, 2017, Scientific Reports.

Genetic Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis: A Systematic Review

A. Catanzaro, T. Rodwell, D. Catanzaro, 2015, PloS one.

MTBDR plus and MTBDR sl Assays: Absence of Wild-Type Probe Hybridization and Implications for Detection of Drug-Resistant Tuberculosis

R. Garfein, T. Victor, A. Catanzaro, 2016 .

MTBDRplus and MTBDRsl Assays: Absence of Wild-Type Probe Hybridization and Implications for Detection of Drug-Resistant Tuberculosis

R. Garfein, T. Victor, C. Rodrigues, 2016, Journal of Clinical Microbiology.

Phenotypic and genotypic diversity in a multinational sample of drug-resistant Mycobacterium tuberculosis isolates.

R. Garfein, T. Ganiats, F. Valafar, 2015, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Using Mycobacterium tuberculosis Single-Nucleotide Polymorphisms To Predict Fluoroquinolone Treatment Response

E. Capparelli, T. Rodwell, D. Catanzaro, 2019, Antimicrobial Agents and Chemotherapy.

Laboratory Evaluation of a Lateral-Flow Cell for Molecular Detection of First-Line and Second-Line Antituberculosis Drug Resistance

R. Colman, C. G. Cooney, D. Catanzaro, 2020, Journal of Clinical Microbiology.

Impact of Fluoroquinolone Use on Mortality Among a Cohort of Patients With Suspected Drug-Resistant Tuberculosis

R. Garfein, T. Rodwell, D. Catanzaro, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Increased Tuberculosis Patient Mortality Associated with Mycobacterium tuberculosis Mutations Conferring Resistance to Second-Line Antituberculous Drugs

R. Garfein, D. Catanzaro, M. Seifert, 2017, Journal of Clinical Microbiology.

Shedding light on the performance of a pyrosequencing assay for drug-resistant tuberculosis diagnosis

R. Garfein, T. Victor, C. Rodrigues, 2016, BMC Infectious Diseases.

Circulating mitochondrial cell-free DNA dynamics in patients with mycobacterial pulmonary infections: Potential for a novel biomarker of disease

Yuh-Min Chen, A. Catanzaro, D. Catanzaro, 2022, Frontiers in Immunology.

Rapid Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates Directly from Clinical Samples by Use of Amplicon Sequencing: a Proof-of-Concept Study

T. Cohen, D. Engelthaler, R. Colman, 2016, Journal of Clinical Microbiology.

Evaluation of Pyrosequencing for Detecting Extensively Drug-Resistant Mycobacterium tuberculosis among Clinical Isolates from Four High-Burden Countries

R. Garfein, M. T. Gler, T. Victor, 2014, Antimicrobial Agents and Chemotherapy.

Detection of Low-Level Mixed-Population Drug Resistance in Mycobacterium tuberculosis Using High Fidelity Amplicon Sequencing

Faramarz Valafar, Paul Keim, David E. Smith, 2015, PloS one.

Evaluation of Genetic Mutations Associated with Mycobacterium tuberculosis Resistance to Amikacin, Kanamycin and Capreomycin: A Systematic Review

R. Garfein, A. Catanzaro, T. Rodwell, 2012, PloS one.

M. Segal, P. Barry, J. Balmes, 2017, Environmental health perspectives.

Residential urban tree canopy is associated with decreased mortality during tuberculosis treatment in California.

P. Barry, J. Balmes, P. Nahid, 2020, The Science of the total environment.

Performance Comparison of Three Rapid Tests for the Diagnosis of Drug-Resistant Tuberculosis

R. Garfein, F. Valafar, T. Victor, 2015, PloS one.

Distinct blood transcriptomic signature of treatment in latent tuberculosis infected individuals at risk of developing active disease.

Julie G. Burel, B. Peters, A. Cunningham, 2021, Tuberculosis.

Frequency and Geographic Distribution of gyrA and gyrB Mutations Associated with Fluoroquinolone Resistance in Clinical Mycobacterium Tuberculosis Isolates: A Systematic Review

T. Ganiats, J. Alcaraz, A. Catanzaro, 2015, PloS one.

Identification of differentially recognized T cell epitopes in the spectrum of Mtb infection

Bjoern Peters, A. Sette, R. Gilman, 2023, bioRxiv.

Frequency and Distribution of Tuberculosis Resistance-Associated Mutations between Mumbai, Moldova, and Eastern Cape

R. Garfein, F. Valafar, T. Victor, 2016, Antimicrobial Agents and Chemotherapy.

CRISPR detection of circulating cell-free Mycobacterium tuberculosis DNA in adults and children, including children with HIV: a molecular diagnostics study

Irene N Njuguna, Christopher J. Lyon, A. Mandalakas, 2022, The Lancet. Microbe.

Cost analysis of rapid diagnostics for drug-resistant tuberculosis

R. Garfein, T. Ganiats, T. Victor, 2018, BMC Infectious Diseases.

Integrating landmark modeling framework and machine learning algorithms for dynamic prediction of tuberculosis treatment outcomes

Shengfan Zhang, V. Crudu, D. Catanzaro, 2022, J. Am. Medical Informatics Assoc..

Clinical Evaluation of the XDR-LFC Assay for the Molecular Detection of Isoniazid, Rifampin, Fluoroquinolone, Kanamycin, Capreomycin, and Amikacin Drug Resistance in a Prospective Cohort

R. Colman, A. Catanzaro, V. Crudu, 2023, Journal of clinical microbiology.

Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates

Faramarz Valafar, Afif Elghraoui, Camilla Rodrigues, 2015, Emerging Microbes & Infections.

A performance evaluation of MTBDRplus version 2 for the diagnosis of multidrug-resistant tuberculosis.

R. Garfein, T. Victor, C. Rodrigues, 2016, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Whole-genome and targeted sequencing of drug-resistant Mycobacterium tuberculosis on the iSeq100 and MiSeq: A performance, ease-of-use, and cost evaluation

Claudia M Denkinger, Anita Suresh, David M Engelthaler, 2019, PLoS medicine.

Predicting Extensively Drug-Resistant Mycobacterium tuberculosis Phenotypes with Genetic Mutations

Faramarz Valafar, Camilla Rodrigues, Nazir Ismail, 2013, Journal of Clinical Microbiology.

Quantifying Uncertainty in Deep Learning Classification with Noise in Discrete Inputs for Risk-Based Decision Making

V. Crudu, D. Catanzaro, Maryam Kheirandish, 2023, ArXiv.

Frequency and Distribution of Tuberculosis Resistance-Associated Mutations between Mumbai, Moldova, and Eastern Cape

R. Garfein, F. Valafar, D. Catanzaro, 2016, Antimicrobial Agents and Chemotherapy.

Asynchronous Video Directly Observed Therapy to Monitor Short-Course Latent Tuberculosis Infection Treatment: Results of a Randomized Controlled Trial

R. Garfein, J. Cuevas-Mota, D. Catanzaro, 2024, Open forum infectious diseases.

Identification of differentially recognized T cell epitopes in the spectrum of tuberculosis infection

A. Sette, V. Crudu, C. L. Lindestam Arlehamn, 2024, Nature communications.

Detecting rifampin and isoniazid resistance in Mycobacterium tuberculosis direct from patient sputum using an automated integrated system

R. Colman, A. Kukhtin, D. Catanzaro, 2022, Journal of clinical tuberculosis and other mycobacterial diseases.